Additionally, targeted AEP inhibitors combined with chemotherapy drugs can significantly reduce the occurrence of bone metastasis in breast cancer and prolong the survival period of mice, by regulating EMT‐related genes and osteoclasts. This evidence concerns the gene LGMN and breast carcinoma.